Chinese Medicine Periodic Therapy for Dysfunctional Uterine Bleeding During Adolescence With Yin Deficiency and Blood Heat Syndrome

Dysfunctional Uterine Bleeding Clinical Trial

Official title:
Efficacy Evaluation of Kidney-tonifying and Tune up Chong-Ren Hemostasis Chinese Medicine Periodic Therapy for Dysfunctional Uterine Bleeding During Adolescence With Yin Deficiency and Blood Heat Syndrome: a Randomized Controlled Study

Status Completed

Clinical Trial Summary

The purpose of this study is to conduct a randomized, single blind, controlled intervention trial to observe the therapeutic effect of kidney-tonifying and tune up Chong-Ren hemostasis Chinese medicine periodic therapy for dysfunctional uterine bleeding based on objective Chinese and western medicine evaluation standard.

Clinical Trial Description

Dysfunctional uterine bleeding during adolescence is the most common menstrual disorders during adolescence, and the age of children suffering from it tended to be lower. It's urgent to explore effective ways to alleviate the pain caused by dysfunctional uterine bleeding. In our research, 160 children are randomly divided into a Chinese medication periodic therapy group (80 cases) and a Gong Xue Ning control group (80 cases). Paticipants in Chinese medication periodic therapy group are treated with kidney-tonifying and tune up Chong-Ren hemostasis Chinese medicine for 3 months, whereas the Gong Xue Ning control group received Gong Xue Ning capsules for 3 months. We compare the effect of the two therapies about hemostasis and menstruation regulation, and the change of the thickness of endometrium, sex hormones, Kisspeptin, and PAI-1 in blood before and after the treatment, in order to make clear the efficacy and the mechanism of the Chinese medicine periodic therapy. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04528108
Study type	Interventional
Source	Children's Hospital of Fudan University
Contact
Status	Completed
Phase	Phase 2
Start date	September 2, 2020
Completion date	July 1, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04428684` - COMPARISON OF A NEW FORMULATION OF GOSERELIN (Pepti 3.6 mg) to Zoladex® 3.6 mg	Phase 1
Recruiting	`NCT00549159` - CavatermTM vs TCRE in Women With DUB	Phase 4
Not yet recruiting	`NCT04579965` - Misotac vs Combined Oral Contraceptive Pill in the Treatment of Symptomatic Isthmocele	N/A
Terminated	`NCT01581905` - Study of Conventional Laparoscopic Hysterectomy Versus Robot-Assisted Laparoscopic Hysterectomy at a Teaching Institution	N/A
Completed	`NCT02326922` - The Use of Levonorgestrel-Releasing Device (Metraplant-E) in the Treatment of Dysfunctional Uterine Bleeding	Phase 1/Phase 2
Recruiting	`NCT04396483` - Dysfunctional Uterine Bleeding After Tubal Sterilization	N/A
Completed	`NCT01628432` - Effect of Salpingectomy During Conservative Hysterectomy	N/A
Terminated	`NCT01776203` - Study of a Progestin to Prevent Bleeding Associated With Initiation of Medical Menopause With GnRH Agonist	Phase 4
Completed	`NCT01148420` - DMPA & High Dose Oral Progestin (MPA) Tablets in Outpatient Treatment of Acute Excessive Vaginal Bleeding	Phase 4
Completed	`NCT01173965` - Endometrial Ablation With Non-hysteroscopic Methods	Phase 4
Active, not recruiting	`NCT02103764` - Efficacy of Cyclic DSG Compared With Cyclic MPA for the Treatment of Anovulatory DUB	Phase 3
Not yet recruiting	`NCT04290013` - Effects of Tranexemic Acid Versus Norethisterone Acetate on Endometrial Vasculature .	Phase 3